BacTech Mining Corporation
TSX VENTURE : BM

BacTech Mining Corporation

June 24, 2008 16:00 ET

BacTech Issues Options

TORONTO, ONTARIO--(Marketwire - June 24, 2008) - BacTech Mining Corporation ("BacTech" or the "Company") (TSX VENTURE:BM) today announced that the Board of Directors has approved the issuance of 975,000 options to purchase common shares of the Company to seven directors, officers and employees, and the issuance of 150,000 options to Pierre Anglos, a consultant providing investor relations services to the Company. The exercise price of the options is $0.15. They are subject to a four-month hold and have a term of 5 years.

The total number of outstanding options under the Company's plan is 5,650,025 or approximately 9.4% of the outstanding shares.

BACTECH PROFILE

BacTech has developed and patented bacterial oxidation technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. BacTech has successfully commissioned three bioleach plants for gold and demonstrated its technology in the selective recovery of base metals from complex sulphide concentrates in a joint project with Industrias Penoles de C.V. of Mexico that was completed in 2001. The Company's focus is the acquisition of equity positions in projects amenable to bioleaching.

Shares outstanding 60,107,206

The TSX Venture Exchange has not reviewed and does not accept any responsibility for the adequacy or accuracy of this release.

Contact Information